Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Total 13F shares
-
868,848
-
Share change
-
-3,417
-
Total reported value
-
$2,592,000
-
Price per share
-
$2.99
-
Number of holders
-
14
-
Value change
-
-$12,512
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2020
As of 31 Dec 2020 Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 868,848 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, RENAISSANCE TECHNOLOGIES LLC, EDGEWOOD MANAGEMENT LLC, BlackRock Inc., STIFEL FINANCIAL CORP, VANGUARD GROUP INC, SeaCrest Wealth Management, LLC, Tower Research Capital LLC (TRC), UBS Group AG, and MORGAN STANLEY.
This table shows 14 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.